Report Overview: The Global Automated Immunoassay Analyzers Market achieved a valuation of $11.53 Billion in 2022 and is anticipated to exceed $35.99 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 15.3% during the forecast period from 2024 to 2032. Key Market Players: Abbott Diagnostics (US), Biokit (Spain), Biomerieux (France), Luminex Corporation (US),...